Re-engineering of TNFα-NF-κB signalling dynamics in cancer cells using pathogenic E. coli effectors
暂无分享,去创建一个
[1] M. Rogg,et al. Proteome alterations during clonal isolation of established human pancreatic cancer cell lines , 2022, Cellular and Molecular Life Sciences.
[2] Yohei Kondo,et al. LIM Tracker: a software package for cell tracking and analysis with advanced interactivity , 2022, Scientific Reports.
[3] C. Bakal,et al. Actin networks modulate heterogenous NF-κB dynamics in response to TNFα , 2022, bioRxiv.
[4] J. Choudhary,et al. EPEC‐induced activation of the Ca2+ transporter TRPV2 leads to pyroptotic cell death , 2021, Molecular microbiology.
[5] Jie Zhou,et al. Risk of Adverse Events After Anti-TNF Treatment for Inflammatory Rheumatological Disease. A Meta-Analysis , 2021, Frontiers in Pharmacology.
[6] J. Garssen,et al. Chemotherapy: a double-edged sword in cancer treatment , 2021, Cancer Immunology, Immunotherapy.
[7] S. Cook,et al. Inhibitory feedback control of NF-κB signalling in health and disease , 2021, The Biochemical journal.
[8] Nichollas E. Scott,et al. NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector , 2021, PLoS pathogens.
[9] Prachi Mishra,et al. The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment , 2021, Frontiers in Immunology.
[10] C. Bakal,et al. Clustering of Tir during enteropathogenic E. coli infection triggers calcium influx–dependent pyroptosis in intestinal epithelial cells , 2020, PLoS biology.
[11] V. Tergaonkar,et al. Small Molecule NF-κB Pathway Inhibitors in Clinic , 2020, International journal of molecular sciences.
[12] Kaiwen W. Chen,et al. Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria , 2020, Nature Communications.
[13] L. Collinson,et al. Human GBP1 Differentially Targets Salmonella and Toxoplasma to License Recognition of Microbial Ligands and Caspase-Mediated Death , 2019, Cell reports.
[14] N. Meyer,et al. The TNF Paradox in Cancer Progression and Immunotherapy , 2019, Front. Immunol..
[15] V. Hornung,et al. Human GBP1 is a microbe‐specific gatekeeper of macrophage apoptosis and pyroptosis , 2019, The EMBO journal.
[16] M. Plebani,et al. Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity , 2019, International journal of molecular sciences.
[17] Hongkai Ji,et al. Transcriptional outcomes and kinetic patterning of gene expression in response to NF-κB activation , 2018, PLoS biology.
[18] D. Munn,et al. Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-α-Dependent Intensification of Oxidative Stress and Tumor Cell Death. , 2018, Cell metabolism.
[19] K. Brown,et al. Tumor immune evasion arises through loss of TNF sensitivity , 2018, Science Immunology.
[20] A. Agresti,et al. NF-κB, the Importance of Being Dynamic: Role and Insights in Cancer , 2018, Biomedicines.
[21] Masahiro Yamamoto,et al. LPS targets host guanylate‐binding proteins to the bacterial outer membrane for non‐canonical inflammasome activation , 2018, The EMBO journal.
[22] R. Hoffman,et al. Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions , 2018, Front. Microbiol..
[23] L. A. Fernández,et al. Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors , 2017, PLoS pathogens.
[24] G. Schmidt,et al. Bacterial Toxins for Cancer Therapy , 2017, Toxins.
[25] Shao-Cong Sun,et al. NF-κB signaling in inflammation , 2017, Signal Transduction and Targeted Therapy.
[26] M. Schmidt,et al. Cell-Penetrating Bacterial Effector Proteins: Better Tools than Targets. , 2017, Trends in biotechnology.
[27] Laura F. Dagley,et al. EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation , 2017, Nature Microbiology.
[28] Zheng Zhang,et al. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma , 2016, Oncotarget.
[29] M. Bianchi,et al. NF-κB oscillations translate into functionally related patterns of gene expression , 2016, eLife.
[30] W. Thabet,et al. Enteropathogenic Escherichia coli (EPEC): Does it have a role in colorectal tumourigenesis? A Prospective Cohort Study. , 2015, International journal of surgery.
[31] Hai-Jie Yang,et al. NF-κB Regulates Caspase-4 Expression and Sensitizes Neuroblastoma Cells to Fas-Induced Apoptosis , 2015, PloS one.
[32] Dinesh Vyas,et al. Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis , 2014, OncoTargets and therapy.
[33] Masahiro Yamamoto,et al. Guanylate binding proteins promote caspase-11–dependent pyroptosis in response to cytoplasmic LPS , 2014, Proceedings of the National Academy of Sciences.
[34] She Chen,et al. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains , 2013, Nature.
[35] T. Bekaii-Saab,et al. Disrupting Cytokine Signaling in Pancreatic Cancer: A Phase I/II Study of Etanercept in Combination With Gemcitabine in Patients With Advanced Disease , 2013, Pancreas.
[36] Hao Wang,et al. Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] J. Lee,et al. NF-κB Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression* , 2012, The Journal of Biological Chemistry.
[38] D. Vaux,et al. IAPs limit activation of RIP kinases by TNF receptor 1 during development , 2012, The EMBO journal.
[39] J. Chen,et al. Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation , 2011, Nature.
[40] R. Zarivach,et al. Metalloprotease type III effectors that specifically cleave JNK and NF‐κB , 2011, The EMBO journal.
[41] Tetsuya Hayashi,et al. NleC, a Type III Secretion Protease, Compromises NF-κB Activation by Targeting p65/RelA , 2010, PLoS pathogens.
[42] J. Turner,et al. Enteropathogenic E. coli non‐LEE encoded effectors NleH1 and NleH2 attenuate NF‐κB activation , 2010, Molecular microbiology.
[43] J. Teissié,et al. Caspase-10-Dependent Cell Death in Fas/CD95 Signalling Is Not Abrogated by Caspase Inhibitor zVAD-fmk , 2010, PloS one.
[44] J. Whisstock,et al. The Type III Effectors NleE and NleB from Enteropathogenic E. coli and OspZ from Shigella Block Nuclear Translocation of NF-κB p65 , 2010, PLoS pathogens.
[45] T. Meyer,et al. The Type III Secretion Effector NleE Inhibits NF-κB Activation , 2010, PLoS pathogens.
[46] B. Finlay,et al. Bacterial Effector Binding to Ribosomal Protein S3 Subverts NF-κB Function , 2009, PLoS pathogens.
[47] F. Balkwill. Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.
[48] Xiaodong Wang,et al. TNF-α Induces Two Distinct Caspase-8 Activation Pathways , 2008, Cell.
[49] H. Wajant,et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. , 2008, Cancer research.
[50] W. Weichert,et al. High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis , 2007, British Journal of Cancer.
[51] M. Nagarkatti,et al. Role of Dioxin Response Element and Nuclear Factor-κB Motifs in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Regulation of Fas and Fas Ligand Expression , 2006, Molecular Pharmacology.
[52] N. Perkins,et al. Good cop, bad cop: the different faces of NF-κB , 2006, Cell Death and Differentiation.
[53] Allan R Brasier,et al. A TNF-induced gene expression program under oscillatory NF-κB control , 2005, BMC Genomics.
[54] P. Barker,et al. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. , 2005, Cancer research.
[55] James R. Johnson,et al. Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.
[56] N. Perkins,et al. Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB , 2004 .
[57] J. Tschopp,et al. Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.
[58] J. Nougayrède,et al. Adhesion of enteropathogenic Escherichia coli to host cells , 2003, Cellular microbiology.
[59] D. Trisciuoglio,et al. relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells , 2001, British Journal of Cancer.
[60] H. Chun,et al. Caspase-10 is an initiator caspase in death receptor signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[61] T. Pawson,et al. Enteropathogenic E. coli Tir binds Nck to initiate actin pedestal formation in host cells , 2001, Nature Cell Biology.
[62] J. Tschopp,et al. NF-κB Signals Induce the Expression of c-FLIP , 2001, Molecular and Cellular Biology.
[63] Peter Scheurich,et al. NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling , 2001, Molecular and Cellular Biology.
[64] Ye Zheng,et al. NF-κB RelA (p65) Is Essential for TNF-α-Induced Fas Expression but Dispensable for Both TCR-Induced Expression and Activation-Induced Cell Death1 , 2001, The Journal of Immunology.
[65] K. Vousden,et al. Role of NF-κB in p53-mediated programmed cell death , 2000, Nature.
[66] Marty W. Mayo,et al. NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis , 1999, Molecular and Cellular Biology.
[67] Peter Scheurich,et al. The Human Tumor Necrosis Factor (TNF) Receptor-associated Factor 1 Gene (TRAF1) Is Up-regulated by Cytokines of the TNF Ligand Family and Modulates TNF-induced Activation of NF-κB and c-Jun N-terminal Kinase* , 1999, The Journal of Biological Chemistry.
[68] Claus Scheidereit,et al. NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.
[69] C. Y. Wang,et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.
[70] Christian Stehlik,et al. Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis , 1998, The Journal of experimental medicine.
[71] B. Finlay,et al. Enteropathogenic E. coli (EPEC) Transfers Its Receptor for Intimate Adherence into Mammalian Cells , 1997, Cell.
[72] Hong-Bing Shu,et al. TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.
[73] Daniel S Waterman,et al. ESCHERICHIA COLI STRAINS THAT CAUSE DIARRHŒA BUT DO NOT PRODUCE HEAT-LABILE OR HEAT-STABLE ENTEROTOXINS AND ARE NON-INVASIVE , 1978, The Lancet.
[74] Abigail Clements,et al. Modulation of Host Cell Processes by T3SS Effectors. , 2018, Current topics in microbiology and immunology.